Immix Biopharma, Inc. Common Stock

S$11.26
SGD
Last updated on --.
24h volume3.65M
24h highest11.7393 SGD
24h lowest11.0176 SGD
24h Price movement+0.46%

IMMX recent prices

24 Hours
+0.46%+S$0.051096
30 days
-6.78%-S$0.8252
60 days
+7.73%+S$0.80476
90 days
+4.64%+S$0.5033

Key data

Previous close11.2156 SGD
Market cap621.38M SGD
Volume3.65M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.81754 SGD
Net income (FY)-44.69M SGD
Revenue (FY)--
Last report date7 May 2026

About Immix Biopharma, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersLOS ANGELES
Employees (FY)21.00
Net income per employee (FY)-2.13M SGD
Listed onNasdaq
Official website

IMMX conversion tables

IMMXIMMX
SGDSGD
0.5 IMMX5.633 SGD
1 IMMX11.26 SGD
5 IMMX56.33 SGD
10 IMMX112.66 SGD
SGDSGD
IMMXIMMX
0.5 SGD0.044379 IMMX
1 SGD0.088757 IMMX
5 SGD0.44379 IMMX
10 SGD0.88757 IMMX

FAQ

IMMX is trading at S$11.26, +0.46% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IMMX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IMMX is currently trading at S$11.26, +0.46% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IMMX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IMMX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IMMX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IMMX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Immix Biopharma, Inc. Common Stock's market cap is currently 621.38M SGD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.65M
24h highest11.7393 SGD
24h lowest11.0176 SGD
24h Price movement+0.46%
IMMXIMMX
SGDSGD
Start trade with IMMX Perpetual